Top Markets
#1 Black Phoenix Black Phoenix +21,531.59%
#2 Nesa Nesa +681.89%
#3 Kinesis Silver Kinesis Silver +55.41%
#4 Ontology Gas Ontology Gas +53.07%
#5 Siren Siren +26.14%
#6 Biconomy Biconomy +24.55%
#7 QuantixAI QuantixAI +23.07%
#8 EXOD EXOD +22.78%
#9 SAFEcoin SAFEcoin +21.29%
#10 BNB Attestation Service BNB Attestation Service +20.95%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Pozycja w akcjach #19061
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Cena akcji
$1.27
Kapitalizacja rynkowa
$176.31M
Zmiana (1 dzień)
5.57%
Zmiana (1 rok)
29.36%
Kraj
TW
Handel Medigen Biotechnology Corp. (3176)

Kategoria

Healthcare
Zyski dla Medigen Biotechnology Corp. (3176)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Medigen Biotechnology Corp., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Medigen Biotechnology Corp. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH